Reuters — Agency’s analysis of Republican health bill may sharpen resistance to measure
A non-partisan report expected as soon as Monday on the costs of a Republican plan to replace the Obamacare healthcare law could harden opposition to the proposal, adding to the obstacles facing President Donald Trump’s first major legislative effort. The Congressional Budget Office, which provides official cost estimates for legislation, is widely expected to find the Republican plan will result in fewer Americans with health insurance than under the Affordable Care Act, former Democratic President Barack Obama’s signature domestic legislation.

The New York Times — F.D.A. official under Bush is Trump’s choice to lead agency
President Trump said Friday that he intended to nominate Scott Gottlieb, a partner at a venture capital fund with longstanding ties to the pharmaceutical and biotech industries, to lead the Food and Drug Administration. The selection of Dr. Gottlieb, 44, who served as a top official at the agency during the administration of President George W. Bush, drew praise from industry executives, who had previously expressed concerns that another top contender, Jim O’Neill, held radical views that would have gutted standards for drug approval trials and testing.

Kaiser Health News — GOP health plan could be bitter pill for California’s Obamacare exchange
California’s insurance exchange, Covered California, features the healthiest mix of customers nationwide, federal data show. That’s been instrumental in holding down rates and boosting enrollment to 1.5 million. Now state and insurance industry officials fear the replacement plan for the Affordable Care Act, introduced by GOP leaders this week, would threaten those gains. They warn that the proposal, which would cut subsidies to lower-income consumers, could undermine the broader market, driving up premiums for the wide range of Californians who purchase their own coverage.

The Washington Post — Employees who decline genetic testing could face penalties under proposed bill
Employers could impose hefty penalties on employees who decline to participate in genetic testing as part of workplace wellness programs if a bill approved by a U.S. House committee this week becomes law.